Catalyst
Slingshot members are tracking this event:
Global Blood Therapeutics Receives FDA Orphan Drug Designation for GBT440 in Sickle Cell Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GBT |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 31, 2015
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Fda, Orphan Drug, Orphan Treatment Designation, Gbt440, Sickle Cell Disease
